LICENSE AGREEMENTS (Details) - USD ($) $ in Millions	1 Months Ended					9 Months Ended
LICENSE AGREEMENTS (Details) - USD ($) $ in Millions	Apr. 30, 2024	Feb. 28, 2023	Jan. 31, 2022	Dec. 31, 2020	Aug. 31, 2017	Mar. 31, 2025
XOMA (US) LLC \| Xoma License Agreement \| Upon Clinical and Regulatory Milestones \| Maximum
License Agreements
Maximum amount of milestone events						$ 30.0
XOMA (US) LLC \| Xoma License Agreement \| After Clinical and Regulatory Milestones \| Maximum
License Agreements
Maximum amount of milestone events						185.0
XOMA (US) LLC \| Phase 2 Clinical Trial RZ358 (ersodetug) \| Xoma License Agreement
License Agreements
Milestone closing payment			$ 2.0
XOMA (US) LLC \| Phase 3 Clinical Trial RZ 358 (ersodetug) \| Xoma License Agreement
License Agreements
Milestone closing payment	$ 5.0
XOMA (US) LLC \| Phase 3 Clinical Trial RZ 358 (ersodetug) \| Xoma License Agreement \| Scenario, Upon Dosing Of The Last Patient
License Agreements
Milestone closing payment						5.0
ActiveSite Pharmaceuticals, Inc \| Development And License Agreement
License Agreements
Royalties percentage					2.00%
ActiveSite Pharmaceuticals, Inc \| Development And License Agreement \| Scenario, Plan \| Maximum
License Agreements
Maximum amount of milestone events					$ 46.5
ActiveSite Pharmaceuticals, Inc \| Phase 1 Clinical Trial RZ402 \| Development And License Agreement
License Agreements
Milestone closing payment				$ 1.0
ActiveSite Pharmaceuticals, Inc \| Phase 2 Clinical Trial RZ402 \| Development And License Agreement
License Agreements
Milestone closing payment		$ 3.0
ActiveSite Pharmaceuticals, Inc \| Phase 3 Clinical Trial RZ 402 \| Development And License Agreement \| Scenario, Plan
License Agreements
Milestone closing payment						$ 5.0